跳至主要内容
临床试验/NCT03661073
NCT03661073已完成不适用

Comprehensive Assessment of Motor Imagery Ability After Stroke

Hospices Civils de Lyon2 个研究点 分布在 1 个国家目标入组 50 人开始时间: 2018年7月17日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
50
试验地点
2
主要终点
Score of vividness

研究概览

简要总结

Individuals with stroke may experience sensory-motor deficit and/or neglect, with possible reduction in motor imagery ability (MI). To our knowledge, no study completely investigated MI ability in one individual whereas MI practice can be performed using visual or kinesthetic modalities (respectively visualizing with mind's eyes or imagining movement using sensation) and internal or external perspectives (performing action as spectator or as actor). This study aims to investigate MI ability in patients with stroke as compared to aged-matched healthy individuals. The investigators will assess explicit MI ability using 3 questionnaires (Movement Imagery Questionnaire-RS - MIQ-RS, Kinesthetic and Visual Imagery Questionnaire-20 - KVIQ-20, Vividness of Movement Imagery Questionnaire-2 - VMIQ-2) and 2 tests (imagined Time Up and Go - iTUG, imagined Box and Block test - iBBT). Outcome parameters will be i) the composite score of vividness measured for all tests using Likert scales, ii) the temporal equivalence between MI and Physical practice (PP - where MI/PP ratio equal to 1 indicate good MI ability and respect of temporal equivalence between MI and PP) and iii) the amplitude of electrodermal activity. The investigators will also study implicit MI ability using a hand laterality judgment task. Outcomes parameters will be response time (i.e. the duration to identify the hand laterality) and the percentage of correct responses.

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Parallel
主要目的
Basic Science
盲法
Single (Investigator)

入排标准

年龄范围
18 Years 至 75 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • For both groups:
  • be more than 18 years old
  • be less than 75 years old
  • benefit from social security
  • For experimental group:
  • patient admitted in Henry Gabrielle hospital for rehabilitation
  • patient with one single episode of stroke

排除标准

  • For patients:
  • sign of cognitive decline (MMSE score under 27/30)
  • evolutionary pathology associated
  • For healthy subjects:
  • neurological or orthopaedical history

结局指标

主要结局

Score of vividness

时间窗: Day 1

Participants will self-report vividness that describe the success in imagining movements using a 5-points Likert scale (1=no image or no sensation to 5=image as clear as PP or sensation as intense as PP) for the KVIQ-20. The investigators will average the vividness for each items of the questionnaire.

次要结局

  • Temporal equivalence measured during KVIQ-20(Day 1)
  • Amplitude of electrodermal responses that will be measured during imagined movement with reference to actual movements measured during VMIQ -2.(Day 1)
  • Amplitude of electrodermal responses that will be measured during imagined movement with reference to actual movements measured during MIQ-RS.(Day 3)
  • Score of vividness measured during iTUG.(Day 5)
  • Temporal equivalence measured during iTUG.(Day 5)
  • Score of vividness measured during MIQ-RS.(Day 3)
  • Response time to identify the hand laterality during the implicit motor imagery ability assessment(Day 3)
  • Amplitude of electrodermal responses that will be measured during imagined movement with reference to actual movements measured during iTUG.(Day 5)
  • Temporal equivalence measured during iBBT.(Day 5)
  • Amplitude of electrodermal responses that will be measured during imagined movement with reference to actual movements measured during KVIQ-20.(Day 1)
  • Score of vividness measured during VMIQ -2(Day 1)
  • Temporal equivalence measured during MIQ-RS.(Day 3)
  • Percentage of correct response to identify the hand laterality during the implicit motor imagery ability assessment(Day 3)
  • Amplitude of electrodermal responses that will be measured during imagined movement with reference to actual movements measured during iBBT.(Day 5)
  • Score of vividness measured during iBBT.(Day 5)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验